ANTARES PHARMA INC - COM (ATRS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2022

Type / Class
Equity / COM
Symbol
ATRS
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ANTARES PHARMA INC - COM (ATRS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q3 4,369 $12,000 -$221,000 $2.75 1
2022 Q2 4,369 $12,000 -$372,367,642 $2.75 1
2022 Q1 91,525,982 $374,618,138 +$24,359,321 $4.10 173
2021 Q4 85,597,159 $305,505,107 +$10,425,249 $3.57 161
2021 Q3 82,376,607 $299,895,468 +$602,429 $3.64 165
2021 Q2 82,142,607 $358,169,821 -$4,684,046 $4.36 173
2021 Q1 82,513,474 $339,492,431 +$37,553,202 $4.11 169
2020 Q4 72,978,549 $291,204,980 +$22,239,126 $3.99 174
2020 Q3 66,894,387 $180,816,482 -$12,531,806 $2.70 163
2020 Q2 71,106,163 $195,236,319 +$14,104,568 $2.75 158
2020 Q1 66,528,367 $156,983,647 -$8,598,086 $2.36 152
2019 Q4 66,453,137 $312,010,389 +$37,061,341 $4.70 155
2019 Q3 60,835,955 $203,515,110 +$1,900,493 $3.34 132
2019 Q2 62,368,661 $205,096,720 -$18,354,602 $3.29 126
2019 Q1 68,828,763 $208,519,331 +$6,926,733 $3.03 129
2018 Q4 66,482,136 $180,798,483 +$12,214,444 $2.72 117
2018 Q3 58,759,019 $197,407,765 -$2,799,825 $3.36 103
2018 Q2 60,936,147 $157,213,069 +$8,048,881 $2.58 98
2018 Q1 58,146,260 $127,920,821 +$6,878,829 $2.20 98
2017 Q4 55,491,150 $110,419,000 +$513,516 $1.99 108
2017 Q3 54,265,866 $175,820,034 -$10,370,307 $3.24 99
2017 Q2 57,508,822 $185,142,930 +$25,182,383 $3.22 102
2017 Q1 49,969,611 $141,911,313 +$3,723,011 $2.84 84
2016 Q4 51,794,038 $120,652,058 +$731,531 $2.33 70
2016 Q3 50,738,077 $85,239,089 -$7,573,794 $1.68 65
2016 Q2 56,339,028 $59,142,180 -$9,988,574 $1.05 70
2016 Q1 66,628,797 $57,977,731 -$1,918,799 $0.87 77
2015 Q4 65,708,181 $79,489,360 -$3,289,683 $1.21 84
2015 Q3 67,431,952 $114,614,037 -$2,929,544 $1.70 87
2015 Q2 68,894,800 $143,297,965 +$45,560,135 $2.08 88
2015 Q1 46,849,659 $126,783,163 +$13,530,536 $2.71 79
2014 Q4 41,883,531 $107,581,350 -$5,908,586 $2.57 85
2014 Q3 41,956,728 $76,808,379 -$9,277,219 $1.83 78
2014 Q2 46,035,622 $122,912,889 -$14,461,181 $2.67 84
2014 Q1 49,802,941 $174,275,161 -$4,122,598 $3.50 89